Navidea Biopharmaceuticals
Last updated: October 12, 2024

CEO Mark Pykett
USA | Funding: $133.8M (+)
Website: http://www.navidea.com/
Navidea Biopharmaceuticals has established a niche in precision medicine. The company focuses on the development and commercialization of diagnostic agents and therapeutics for cancer, autoimmune diseases, dementia, and movement disorders.
Website: http://www.navidea.com/
Navidea Biopharmaceuticals has established a niche in precision medicine. The company focuses on the development and commercialization of diagnostic agents and therapeutics for cancer, autoimmune diseases, dementia, and movement disorders.

